pharma · Solid Tumors · Primary Dysmenorrhea
Topiloric/Uriadec
Topiloric/Uriadec is a pharma organization headquartered in SOUTH SAN FRANCISCO, CA, JP. Primary therapeutic focus areas include Solid Tumors, Primary Dysmenorrhea, Prostate cancer, chronic liver disease, Prostatic Neopl
SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- SOUTH SAN FRANCISCO, CA, JP
- Employees
- 2
- Programs
- 12
- Drugs
- 7
- Patents
- 52
ORIC-101
Phase 1 · small molecule · Solid Tumor
ORIC-101 for Solid Tumor is a Phase 1 program (small_molecule) at Topiloric/Uriadec with 1 ClinicalTrials.gov record(s).
Internal code 101-18101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Topiloric/Uriadec
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Solid Tumor
- Status
- terminated
- Trials
- 1